The gastrointestinal tract microbiome, probiotics, and mood

Inflammopharmacology

Volumn 22, Issue 6, 2014, Pages 333-339

  Vitetta, Luis ^a,b   Bambling, Matthew ^c   Alford, Hollie ^a,b  

^a Medlab   (Australia)

^b UNIVERSITY OF SYDNEY   (Australia)

^c UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

Depression; Dysbiosis; Gastrointestinal tract; Microbiome; Mood; Nutraceuticals; Prebiotics; Probiotics

Indexed keywords

PROBIOTIC AGENT; REACTIVE OXYGEN METABOLITE;

DEPRESSIVE DISORDER, MAJOR; DIET SUPPLEMENTATION; GASTROINTESTINAL TRACT; HUMAN; METABOLISM; MICROBIOLOGY; MICROFLORA; MOOD DISORDERS; OXIDATIVE STRESS; PHYSIOLOGY;

DEPRESSIVE DISORDER, MAJOR; DIETARY SUPPLEMENTS; GASTROINTESTINAL TRACT; HUMANS; MICROBIOTA; MOOD DISORDERS; OXIDATIVE STRESS; PROBIOTICS; REACTIVE OXYGEN SPECIES;

EID: 84937216109     PISSN: 09254692     EISSN: 15685608     Source Type: Journal    
DOI: 10.1007/s10787-014-0216-x     Document Type: Article

References (51)

1. Amalaradjou MA, Bhunia AK (2012) Modern approaches in probiotics research to control foodborne pathogens. Adv Food Nutr Res 67:185–239
2. Andrews G, Hall W, Teeson M, Henderson S (1999) The mental health of Australians. Commonwealth Department of Health and Aged Care, Canberra
3. Benton D, Williams C, Brown A (2007) Impact of consuming a milk drink containing a probiotic on mood and cognition. Eur J Clin Nutr 61:355–361
4. Berk M, Williams LJ, Jacka FN et al (2013) So depression is an inflammatory disease, but where does the inflammation come from? BMC Med 11:200
5. Black DW, Bell S, Hulbert J, Nasrallah A (1988) The importance of axis II diagnoses in patients with major depression. J Affect Disord 14:115–122
6. Bravo JA, Forsythe P, Chew MV et al (2011) Ingestion of Lactobacillus strain regulates emotional behavior and central GABA receptor expression in a mouse via the vagus nerve. PNAS 108:16050–16055
7. Brophy JJ (1994) Personality disorder, symptoms and dexamethasone suppression in depression. Affect Disord 31:19–27
8. Calanni F, Renzulli C, Barbanti M, Viscomi GC (2014) Rifaximin: beyond the traditional antibiotic activity. J Antibiot (Tokyo). doi: 10.1038/ja.2014.106
9. Clarke G, Grenham S, Scully P et al (2013) The microbiome-gut-brain axis during early life regulates the hippocampal serotonergic system in a sex-dependent manner. Mol Psychiatry 18(6):666–673
10. Collins SM, Bercik P (2009) The relationship between intestinal microbiota and the central nervous system in normal gastrointestinal function and disease. Gastroenterology 136:2003–2014
11. Cotter PD, Stanton C, Ross RP, Hill C (2012) The impact of antibiotics on the gut microbiota as revealed by high throughput DNA sequencing. Discov Med 13(70):193–199
12. Cryan JF, O’Mahony SM (2011) The microbiome-gut-brain axis: from bowel to behavior. Neurogastroenterol Motil 23:187–192
13. Dinan TG, Cryan JF (2013) Melancholic microbes: a link between gut microbiota and depression? Neurogastroenterol Motil 25:713–719
14. Dinan TG, Stanton C, Cryan JF (2013) Psychobiotics: a novel class of psychotropic. Biol Psychiatry 74(10):720–726
15. Fava M (2010) Switching treatments for complicated depression. J Clin Psychiatry 71(2):e04
16. Foster JA, McVey Neufeld KA (2013) Gut–brain axis: how the microbiome influences anxiety and depression. Trends Neurosci 36(5):305–312
17. Furness JB, Rivera LR, Cho HJ et al (2013) The gut as a sensory organ. Nat Rev Gastroenterol Hepatol 10(12):729–740
18. Halmos EP, Christophersen CT, Bird AR et al (2014) Diets that differ in their FODMAP content alter the colonic luminal microenvironment. Gut. doi: 10.1136/gutjnl-2014-307264
19. Hungin AP, Mulligan C, Pot B et al (2013) Systematic review: probiotics in the management of lower gastrointestinal symptoms in clinical practice—an evidence-based international guide. Aliment Pharmacol Ther 38(8):864–886
20. Katon W, Russo J, Von Korff M et al (2002) Long-term effects of a collaborative care intervention in persistently depressed primary care patients. J Gen Intern Med 17(10):741–748
21. Kiloh LG, Andrews G, Neilson M (1988) The long term outcomes of depression. Br J Psychiatry 153:752–759
22. Lee AS, Murray RM (1988) The long-term outcome of Maudsley depressives. Br J Psychiatry 153:741–751
23. Loenen W (2006) S-adenosylmethionine: Jack of all trades and master of everything? Biochem Soc Trans 34(Pt 2):330–333
24. Lyte M (2011) Probiotics function mechanistically as delivery vehicles for neuroactive compounds: Microbial endocrinology in the design and use of probiotics. BioEssays 33:574–581
25. Maes M, Kubera M, Leunis JC et al (2013) In depression, bacterial translocation may drive inflammatory responses, oxidative and nitrosative stress (O&NS), and autoimmune responses directed against O&NS-damaged neoepitopes. Acta Psychiatr Scand 127(5):344–354
26. Messaoudi M, Lalonde R, Violle N et al (2011) Assessment of psychotropic-like properties of a probiotic formulation (Lactobacillus helveticus R0052 and Bifidobacterium longum R0175) in rats and human subjects. Br J Nutr 105:755–764
27. Morris KV, Mattick JS (2014) The rise of regulatory RNA. Nat Rev Genet 15(6):423–437
28. Najm WI, Reinsch S, Hoehler F et al (2004) S-adenosyl methionine (SAMe) versus celecoxib for the treatment of osteoarthritis symptoms: a double-blind cross-over trial. ISRCTN36233495. BMC Musculoskelet Disord 5:6
29. National Collaborating Centre for Mental Health (UK) (2010) Leicester (UK): British Psychological Society. National Institute for Health and Clinical Excellence: Guidance. Depression: the treatment and management of depression in adults (Updated Edition)
30. Naviaux RK (2014) Metabolic features of the cell danger response. Mitochondrion 16:7–17
31. Neish AS (2013) Redox signaling mediated by the gut microbiota. Free Radic Res 13 [Epub ahead of print]
32. Nestler EJ, Barrot M, DiLeone RJ et al (2002) Neurobiology of depression. Neuron 34(1):13–25
33. Papakostas GI, Mischoulon D, Shyu I et al (2010) S-adenosyl methionine (SAMe) augmentation of serotonin reuptake inhibitors for antidepressant nonresponders with major depressive disorder: a double-blind, randomized clinical trial. Am J Psychiatry 167(8):942–949
34. Perovic B, Jovanovic M, Miljkovic B, Vezmar S (2010) Getting the balance right: established and emerging therapies for major depressive disorders. Nuropsychiatr Dis Treat 7(6):343–364
35. Piccinelli M, Wilkingson G (1994) Outcome of depression in psychiatric settings. Br J Psychiatry 164:297–304
36. Rao AV, Bested AC, Beaulne TM et al (2009) A randomized, double-blind, placebo-controlled pilot study of a probiotic in emotional symptoms of chronic fatigue syndrome. Gut Pathog 1:6
37. Roshchina VV (2010) Evolutionary considerations of neurotransmitters in microbial, plant, and animal cells. In: Lyte M, Freestone PPE (eds) Microbial endocrinology: interkingdom signaling in infectious disease and health. Springer, New York, pp 17–52
38. Schousboe A, Waagepetersen HS (2007) GABA: homeostatic and pharmacological aspects. In: Tepper JM, Abercrombie ED, Bolam JP (eds) GABA and the basal ganglia: from molecules to systems, vol 9–19. Elsevier Science B, Amsterdam
39. Shea TM, Glass DR, Pilkonis PA et al (1987) Personality disorders and treatment outcome in the NIMH Treatment of Depression Collaborative Research Program. J Personal Disord 1:27–42
40. Staudacher H, Lomer MCE, Anderson J et al (2012) Fermentable carbohydrate restriction reduces luminal bifidobacteria and gastrointestinal symptoms in patients with irritable bowel syndrome. J Nutr 142:1510–1518
41. Tan M, Zhu JC, Du J et al (2011) Effects of probiotics on serum levels of Th1/Th2 cytokine and clinical outcomes in severe traumatic brain-injured patients: a prospective randomized pilot study. Crit Care 15:R290
42. Tillisch K, Labus J, Kilpatrick L et al (2013) Consumption of fermented milk product with probiotic modulates brain activity. Gastroenterology 144:1394–1401 1401 e1391-1394
43. Timmerman HM, Koning CJ, Mulder L et al (2004) Monostrain, multistrain and multispecies probiotics—a comparison of functionality and efficacy. Int J Food Microbiol 96:219–233
44. Vitetta L, Anton B, Cortizo F, Sali A (2005) Mind-body medicine: stress and its impact on overall health and longevity. Ann NY Acad Sci 1057:492–505
45. Vitetta L, Briskey D, Hayes E et al (2012) A review of the pharmacobiotic regulation of gastrointestinal inflammation by probiotics, commensal bacteria and prebiotics. Inflammopharmacology 20:251–266
46. Vitetta L, Linnane AW, Gobe GC (2013a) From the gastrointestinal tract (GIT) to the kidneys: live bacterial cultures (probiotics) mediating reductions of uremic toxin levels via free radical signaling. Toxins (Basel) 5(11):2042–2057
47. Vitetta L, Couslon S, Linnane AW, Butt H (2013b) The gastrointestinal microbiome and musculoskeletal diseases: is there a role for probiotics and prebiotics? Pathogens 2:606–626
48. Waters LS, Storz G (2009) Regulatory RNAs in bacteria. Cell 136(4):615–628
49. WHO (2012) World Health Organisation, depression burden of disease. http://www.who.int/mediacentre/factsheets/fs369/en/. Accessed August 2014
50. Yang X, Xie L, Li Y, Wei C (2009) More than 9,000,000 unique genes in human gut bacterial community: estimating gene numbers inside a human body. PLoS One 4:e6074
51. Zoetendal EG, Rajilic-Stojanovic M, de Vos WM (2008) High-throughput diversity and functionality analysis of the gastrointestinal tract microbiota. Gut 57:1605–1615